Lobbying client
3-V BIOSCIENCES, INC.
Development of pharmaceuticals to address unmet needs in infectious disease
Filings
10
Filed by
1
Reported in-house
—
Reported by firms
$300,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2009 to 2010
Filings
10 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination Amendment 2nd Quarter 2010
|
FABIANI & COMPANY | $50,000 reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2010
|
FABIANI & COMPANY | $50,000 reported |
|
1st Quarter - Report 1st Quarter 2010
|
FABIANI & COMPANY | $50,000 reported |
|
4th Quarter - Report 4th Quarter 2009
|
FABIANI & COMPANY | $50,000 reported |
|
3rd Quarter - Report 3rd Quarter 2009
|
FABIANI & COMPANY | $50,000 reported |
|
2nd Quarter - Report 2nd Quarter 2009
|
FABIANI & COMPANY | $50,000 reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2009
|
FABIANI & COMPANY | $50,000 reported |
|
1st Quarter - Report 1st Quarter 2009
|
FABIANI & COMPANY | $50,000 reported |
|
Registration - Amendment 1st Quarter 2009
|
FABIANI & COMPANY | — reported |
|
Registration 1st Quarter 2009
|
FABIANI & COMPANY | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FABIANI & COMPANY | 6 | $300,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Defense | DEF | 8 |
| Health Issues | HCR | 8 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.